Compare Reddit Inc (RDDT) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reddit Inc vs Sanofi SA — how do they compare? Reddit Inc trades at $159.84 (market cap $30.10B), while Sanofi SA trades at $40.07 (market cap $95.18B). The key difference: Sanofi SA is far larger — about 3.2× Reddit Inc's market cap, and Sanofi SA pays a 6.01% dividend while Reddit Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Reddit Inc for 26 Days and Sanofi SA for 94 Days on average.
| RDDT | SNY | |
|---|---|---|
Market Cap | $30.10B | $95.18B |
Volume | 4,560,440 | 2,995,646 |
Sector | Media | Health |
52-Week High | $258.93 | $52.34 |
52-Week Low | $121.84 | $39.51 |
Typical Hold Time | 26 Days | 94 Days |
Enterprise Value | $27.34B | $114.48B |
Dividend Yield | — | 6.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $156.49, up 2.44% today, showing strong momentum after recent earnings beats. The stock maintains a bullish technical outlook with support at $154 and resistance at $158. Fundamentally, the company demonstrates exceptional profitability with 91.44% gross margins and 31.35% net income margins, though valuation metrics remain elevated with a P/E of 36.39. Recent news highlights strategic partnerships and international expansion driving growth.
Outlook remains positive with analyst consensus at $202.52 (29% upside) and 65% buy ratings. Key opportunities include AI data licensing growth and international monetization, while risks involve competitive pressures and potential valuation compression given premium multiples. The company's transition to profitability and strong cash flow generation support continued expansion.
Sanofi (SNY) trades at $40.23, up 0.07% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings beat with EPS of $1.21 versus $1.10 expected, continuing a trend of exceeding expectations. Recent expansion of the immunology alliance with Regeneron adds potential for future growth through new antibody programs.
While valuation metrics appear reasonable with P/E of 22.14 and P/S of 1.77, projected 2026 net income decline to $4.0B (8.09% margin) raises concerns. Analyst consensus leans cautious with 44% buy ratings versus 52% hold, suggesting tempered optimism despite recent positive developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
